MedTrace Logo

Dengue Effectiveness Study in the Philippines

NCT03803618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2081

Last updated 2023-05-17

No results posted yet for this study

Summary

This is an observational study that aims to determine the effectiveness of a tetravalent dengue vaccine (CYD-TDV) when given through a community-based immunization program against hospitalized and /or severe virologically confirmed dengue.

Conditions

  • Dengue
  • Severe Dengue
  • Virologically Confirmed Dengue

Sponsors & Collaborators

  • Sanofi Pasteur, a Sanofi Company

    collaborator INDUSTRY

  • Research Institute for Tropical Medicine, Philippines

    collaborator OTHER_GOV

  • University of the Philippines

    lead OTHER

Principal Investigators

  • Jacqueline L. Deen, MD · UPM - NIH, Institute of Child Health and Human Development

Eligibility

Min Age
9 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2022-11-30
Completion
2023-04-30

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803618 on ClinicalTrials.gov